Skip to content

Clinical trials

Completed Phase 1/2 Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 1/2 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20073
20081
20091
20103
20133
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ironshore Pharmaceuticals and Development, Inc2
Children's Hospital Medical Center, Cincinnati1
Cingulate Therapeutics1
Climb Up Kids1
CoMentis1
Medical University of Warsaw1
NeuroDerm Ltd.1
New River Pharmaceuticals1
Obslap Research LLC1
Oregon Health and Science University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity16
Dyslexia2
Amphetamine-Related Disorders1
Asperger Syndrome1
Autism Spectrum Disorder1
Brain Injuries, Traumatic1
Cerebral Palsy1
Developmental Disabilities1
Language Development Disorders1
Speech Disorders1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.